Answers are grounded in this paper and cite their sources.
Staphylococcus aureus is a prevalent cause of bacterial infections associated with indwelling medical devices. RNA III inhibiting peptide (RIP) is known to inhibit S. aureus pathogenesis by disrupting quorum-sensing mechanisms. RIP was tested in the present study for its ability to inhibit S. aureus biofilm formation in a rat Dacron graft model. The activity of RIP was synergistic with those of antibiotics for the complete prevention of drug-resistant S. aureus infections.
No takes yet. Share an insight, caveat, or question.
Cirioni et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: